Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04927377 · ClinicalTrials.gov registry record · NA

Accessible and Inclusive Diabetes Telecoaching Self-Management Program

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
90
Enrollment target

NCT04927377 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 90 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04927377, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target

Study Summary

The purpose of this study is to develop and pilot test an accessible and inclusive Artificial Intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4DM) for glycemic control in people with disabilities.

Interventions

  • BEHAVIORAL Attention-control
  • BEHAVIORAL AI4DM

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2022-10-31
Est. Completion 2025-09-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04927377

The ClinicalTrials.gov registry entry for NCT04927377 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Attention-control is the first listed.

NCT04927377 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04927377 about?

NCT04927377 is a clinical study titled "Accessible and Inclusive Diabetes Telecoaching Self-Management Program". The purpose of this study is to develop and pilot test an accessible and inclusive Artificial Intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4DM) for glycemic control in people with disabilities.

What is the current status of trial NCT04927377?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2022-10-31. Estimated completion is 2025-09-30.

What interventions are being tested in trial NCT04927377?

The interventions under investigation include: Attention-control (BEHAVIORAL), AI4DM (BEHAVIORAL).

Who is sponsoring clinical trial NCT04927377?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.